GOLDMAN SACHS GROUP INC - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 84 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$29,000
+3.6%
52,822
+0.2%
0.00%
Q1 2016$28,000
-50.9%
52,730
-17.6%
0.00%
Q4 2015$57,000
-41.2%
63,982
-46.4%
0.00%
Q3 2015$97,000
-94.3%
119,335
-78.9%
0.00%
-100.0%
Q2 2015$1,704,000
+82.4%
566,120
+48.5%
0.00%
Q1 2015$934,000
+195.6%
381,237
+207.8%
0.00%
Q4 2014$316,000
-93.0%
123,876
-80.4%
0.00%
-100.0%
Q3 2014$4,520,000
+3431.2%
632,971
+3116.8%
0.00%
Q2 2014$128,000
-73.3%
19,677
-72.8%
0.00%
Q1 2014$479,000
-61.9%
72,472
-72.7%
0.00%
Q4 2013$1,257,000
+1032.4%
265,182
+1087.0%
0.00%
Q3 2013$111,000
+42.3%
22,340
+48.8%
0.00%
Q2 2013$78,000
-79.8%
15,015
-83.7%
0.00%
Q4 2012$386,000
+160.8%
91,840
+247.9%
0.00%
Q3 2012$148,00026,3960.00%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 3,500,000$8,576,0001.54%
GREAT POINT PARTNERS LLC 1,038,652$2,545,0001.12%
BVF INC/IL 1,893,030$4,638,0000.97%
Healthcare Value Capital, LLC 200,000$490,0000.53%
Healthcare Value Capital, LLC 200,000$490,0000.53%
SPHERA FUNDS MANAGEMENT LTD. 1,300,000$3,185,0000.33%
DSC Advisors, L.P. 225,000$551,0000.29%
Perceptive Advisors 700,000$1,715,0000.13%
DSC Advisors, L.P. 400,000$240,0000.13%
Endurant Capital Management LP 140,000$343,0000.11%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders